Option Care Health (NASDAQ:OPCH) Rating Increased to Hold at Zacks Research

Zacks Research upgraded shares of Option Care Health (NASDAQ:OPCH) from a strong sell rating to a hold rating in a research note released on Monday,Zacks.com reports.

Several other research analysts have also issued reports on the stock. UBS Group restated a “buy” rating on shares of Option Care Health in a research report on Tuesday, June 16th. Barrington Research reduced their price objective on Option Care Health from $42.00 to $32.00 and set an “outperform” rating for the company in a research note on Friday, May 1st. JPMorgan Chase & Co. reduced their price objective on Option Care Health from $40.00 to $33.00 and set an “overweight” rating for the company in a research note on Monday, May 4th. Morgan Stanley set a $28.00 target price on Option Care Health in a report on Wednesday, May 6th. Finally, Truist Financial set a $30.00 target price on Option Care Health in a research report on Friday, May 1st. One research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and five have given a Hold rating to the company. Based on data from MarketBeat, Option Care Health presently has an average rating of “Moderate Buy” and a consensus target price of $30.54.

Option Care Health Stock Performance

NASDAQ:OPCH opened at $21.57 on Monday. Option Care Health has a twelve month low of $18.01 and a twelve month high of $36.80. The company has a current ratio of 1.64, a quick ratio of 1.07 and a debt-to-equity ratio of 0.85. The company has a 50-day moving average of $21.39 and a 200-day moving average of $28.06. The firm has a market cap of $3.39 billion, a price-to-earnings ratio of 16.72, a price-to-earnings-growth ratio of 1.19 and a beta of 0.65.

Option Care Health (NASDAQ:OPCH) last released its earnings results on Thursday, April 30th. The company reported $0.40 EPS for the quarter, topping analysts’ consensus estimates of $0.37 by $0.03. Option Care Health had a net margin of 3.64% and a return on equity of 18.17%. The business had revenue of $1.35 billion for the quarter, compared to the consensus estimate of $1.39 billion. During the same period in the previous year, the firm earned $0.40 EPS. The business’s revenue for the quarter was up 1.3% on a year-over-year basis. Option Care Health has set its FY 2026 guidance at 1.820-1.920 EPS. Analysts forecast that Option Care Health will post 1.64 earnings per share for the current fiscal year.

Insider Activity

In other news, Director Timothy P. Sullivan purchased 24,154 shares of Option Care Health stock in a transaction that occurred on Thursday, May 7th. The stock was acquired at an average price of $20.69 per share, for a total transaction of $499,746.26. Following the transaction, the director owned 73,383 shares in the company, valued at $1,518,294.27. The trade was a 49.06% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available at this link. Also, CEO John Charles Rademacher acquired 12,500 shares of the firm’s stock in a transaction that occurred on Monday, May 4th. The stock was purchased at an average cost of $21.18 per share, with a total value of $264,750.00. Following the purchase, the chief executive officer directly owned 695,152 shares in the company, valued at approximately $14,723,319.36. This trade represents a 1.83% increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders have bought 73,264 shares of company stock worth $1,548,316 over the last 90 days. 1.70% of the stock is owned by company insiders.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of the business. V Square Quantitative Management LLC purchased a new stake in Option Care Health in the 4th quarter worth about $25,000. McIlrath & Eck LLC purchased a new position in Option Care Health during the 2nd quarter valued at about $37,000. Advisory Services Network LLC acquired a new position in shares of Option Care Health in the 3rd quarter valued at about $35,000. Caitong International Asset Management Co. Ltd acquired a new position in shares of Option Care Health in the 3rd quarter valued at about $38,000. Finally, Employees Retirement System of Texas purchased a new stake in shares of Option Care Health in the fourth quarter worth approximately $45,000. Hedge funds and other institutional investors own 98.05% of the company’s stock.

Option Care Health Company Profile

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.